{"id":15616,"date":"2024-12-23T09:30:00","date_gmt":"2024-12-23T09:30:00","guid":{"rendered":"https:\/\/www.gecp.pt\/?p=15616"},"modified":"2024-12-22T11:54:59","modified_gmt":"2024-12-22T11:54:59","slug":"entrevista-prof-suresh-senan","status":"publish","type":"post","link":"https:\/\/www.gecp.pt\/en\/entrevista-prof-suresh-senan\/","title":{"rendered":"Interview Prof. SUESH SENAN"},"content":{"rendered":"<p>At the &#8220;Round Table: Unpaid Surgical Stages&#8221;, Prof. SURESH SENAN explored the news in the combination of radiotherapy immunotherapy.<\/p>\n<p>In his presentation, entitled &#8220;Immunotherapy + Radiotherapy: What&#8217;s New,&#8221; highlighted two major studies in which these two therapies &#8220;can improve the survival of lung cancer patients of no small inoperable cells, as well as cancer patients with cancer Small cell lung &#8220;. It also emphasized that this is a &#8220;significant advance, because the benefits are substantial, without increasing toxicity.&#8221;<\/p>\n<p>The expert also addressed cases where this combination is more recommended and how it can contribute to maintaining the quality of life of patients, helping to prolong survival.<\/p>\n<p>Get to know the key messages of Prof. SURESH SENAN Seeing the video.<!--themify_builder_content-->\n<div id=\"themify_builder_content-15616\" data-postid=\"15616\" class=\"themify_builder_content themify_builder_content-15616 themify_builder tf_clear\">\n                    <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_mgbe249 tb_first tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_riar250 first\">\n                    <!-- module video -->\n<div  class=\"module module-video tb_0d3v118 video-top\" data-lazy=\"1\">\n                    <div class=\"video-wrap-outer\">\n            <div class=\"video-wrap tf_rel tf_overflow\">\n                                    <noscript><iframe data-no-script src=\"https:\/\/www.youtube.com\/embed\/1d0WH9nPg1Q?pip=1&#038;playsinline=1\" allow=\"accelerometer;encrypted-media;gyroscope;picture-in-picture;fullscreen\" class=\"tf_abs tf_w tf_h\"><\/iframe><\/noscript>\n                                <\/div>\n            <!-- \/video-wrap -->\n        <\/div>\n        <!-- \/video-wrap-outer -->\n            <\/div>\n        <\/div>\n                        <\/div>\n        <\/div>\n        <\/div>\n<!--\/themify_builder_content--><\/p><!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>At the &#8220;Round Table: Unpaid Surgical Stages&#8221;, Prof. SURESH SENAN explored the news in the combination of radiotherapy immunotherapy. In his presentation, entitled &#8220;Immunotherapy + Radiotherapy: What&#8217;s New,&#8221; highlighted two major studies in which these two therapies &#8220;can improve the&#8230;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>","protected":false},"author":1,"featured_media":15628,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ngg_post_thumbnail":0},"categories":[119,183,118,160],"tags":[],"_links":{"self":[{"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/15616"}],"collection":[{"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/comments?post=15616"}],"version-history":[{"count":8,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/15616\/revisions"}],"predecessor-version":[{"id":15642,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/posts\/15616\/revisions\/15642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/media\/15628"}],"wp:attachment":[{"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/media?parent=15616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/categories?post=15616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gecp.pt\/en\/wp-json\/wp\/v2\/tags?post=15616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}